Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FWUWD
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,376
Award facts
- Contract value 100% obligated
- $10,375.53 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $10,375.53 delivery order to DMS Pharmaceutical Group Inc. on September 5, 2025, for the supply of Nuplazid 34 mg capsules in quantities of 30 units. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, carries no set-aside designation and will be performed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was selected to fulfill this requirement through its existing Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026 under the SPE2DB program.
Nuplazid is an antipsychotic medication primarily indicated for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. This delivery order represents a routine pharmaceutical supply need within the Defense Logistics Agency's broader mission of supporting Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established portfolio as a federal pharmaceutical supplier, combined with its woman-owned small business status and comprehensive drug distribution capabilities, positions the company to efficiently deliver specialized pharmaceutical products to military medical installations across the nation.
Quick answers
Who was awarded contract SPE2DB25FWUWD?
SPE2DB25FWUWD was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 5, 2025.
How much is contract SPE2DB25FWUWD worth?
The government has obligated $10,376 on SPE2DB25FWUWD.
Is contract SPE2DB25FWUWD an order under another contract?
Yes. SPE2DB25FWUWD is a delivery order under SPE2DB25D9312, an indefinite delivery contract.
Was contract SPE2DB25FWUWD competed?
The extent of competition for SPE2DB25FWUWD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award